Recon Strategy
Contact

Insights

Fifteen+ years of
healthcare thinking.

Several hundred perspectives on the questions facing payers, providers, biopharma, medtech, and digital health — plus our running read on the clinical literature. Start with our sharpest work, or filter to your world.

ESSENTIAL READING

  • Biopharma, Payers, Institutional

Outcomes Based Arrangements in Biopharma

Today’s advanced therapies target devastating diseases with high unmet need. Given the urgent medical need (and pressure from patient advocates), regulators increasingly must make decisions based on early, incomplete data when it comes to durability, real-world effectiveness, and cost-effectiveness – all while bearing costs that can exceed $1 million per patient.
  • Biopharma

A few thoughts about navigating biopharma macro scenarios

Planning biopharma strategies against a robust set of macro-scenarios will be crucial to mid- and long-term success. While historically these scenarios have revolved around targeted issues, the current challengescall for a more expansive - and likely more difficult - set of questions to be asked.
  • Biopharma, Payers, Providers, Medtech, Digital

Why the Best AI Won’t Win in Healthcare

As advanced AI becomes widely accessible, healthcare companies can no longer rely on superior technology alone for lasting advantage. Instead, they need a coherent AI strategy built around five interconnected choices. Harvard Business Review article.
Sector
All
NEJM opinion

An opinionated take on NEJM highlights for November 2019

  • NEJM
A triumph for cystic fibrosis patients (and for Vertex) Phase 3 confir…

Read more

An opinionated take on NEJM highlights for October 2019

  • NEJM
Genomic applications and scalability Two very different papers about a…

Read more

An opinionated take on NEJM highlights for September 2019

  • NEJM
Best care vs. good care In wealthy countries, the recommended standard…

Read more

Bolting a full-risk engine onto an urgent care chassis in New York

  • Payers , 
  • Providers
Last month, Warburg Pincus closed on previously announced plans to acq…

Read more

Busy summer: An opinionated take on NEJM highlights for July/August 2019

  • NEJM
Is the lack of new (non-viral) antibiotics a market failure? A lament…

Read more

Choosing your customers wisely: are hospitals the right place to engineer the future of healthcare (and the software services to support it)?

  • Providers , 
  • Digital
MSFT’s pathbreaking alliances in healthcare services are impressive an…

Read more

Fishing for nucleic acids: An opinionated take on NEJM highlights for June 2019

  • NEJM
Huntington’s disease: light at the end of the tunnel? The awful thing…

Read more

Full-service vs. self-service: an emerging bifurcation in healthcare

  • Providers
A clinical vignette: the cases of Jane and Joe Imagine if you will tw…

Read more

Facing new vertically integrated competitors, WellSpan and Capital Blue Cross prepare for a long siege

  • Payers , 
  • Providers
Summary The Capital Region of Pennsylvania is shifting in “real time”…

Read more

SELECTED ENGAGEMENTS

Insight, put to work

Our published thinking is one half of the picture. These are representative client engagements, anonymized — each tagged by sector, so you can trace the path from perspective to practice.

  • Institutional

Strategy for Statewide Health Information Exchange

A non-profit health information exchange was facing financial struggles and needed a new strategy that would keep it financially sustainable

HIE, Health IT,

  • Medtech, Early Stage

Growth strategy for point-of-care testing

Post pandemic an innovative diagnostics platform company wanted to dramatically increase its market by targeting retail clinics for its point-of-care diagnostics platform

Growth, product market fit, value proposition

  • Institutional

University Trials

Large university wanting to dramatically increase its clinical research footprint

Keep up with Recon Strategy Insights
Get an email each time we publish a new article